No Financial Advisor. Except as set forth on Section 2.24 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 2 contracts
Samples: Agreement and Plan of Merger and Reorganization (Emmaus Life Sciences, Inc.), Agreement and Plan of Merger and Reorganization (MYnd Analytics, Inc.)
No Financial Advisor. Except as set forth on in Section 2.24 2.25 of the Company Disclosure ScheduleSchedule of Exceptions, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Innovate Biopharmaceuticals, Inc.), Agreement and Plan of Merger and Reorganization (Innovate Biopharmaceuticals, Inc.)
No Financial Advisor. Except as set forth on Section 2.24 2.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Targacept Inc), Agreement and Plan of Merger and Reorganization (Zalicus Inc.)
No Financial Advisor. Except as set forth on Section 2.24 Part 2.19 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger Transaction or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Share Purchase Agreement (Carbylan Therapeutics, Inc.)
No Financial Advisor. Except as set forth on Section 2.24 in Part 2.22 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Yumanity Therapeutics, Inc.)
No Financial Advisor. Except as set forth on Section 2.24 3.18 of the Company Vital Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the CompanyVital.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.24 Part 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Tranzyme Inc)
No Financial Advisor. Except as set forth on Section 2.24 2.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Synta Pharmaceuticals Corp)
No Financial Advisor. Except as set forth on Section 2.24 Part 3.19 of the Company Lpath Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Lpath or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Lpath, Inc)
No Financial Advisor. Except as set forth on Section 2.24 2.26 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Second Sight Medical Products Inc)
No Financial Advisor. Except as set forth on Section 2.24 Part 2.21 of the Company Buyer Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Buyer or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Lpath, Inc)
No Financial Advisor. Except as set forth on in Section 2.24 3.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Business Combination Agreement (KBL Merger Corp. Iv)
No Financial Advisor. Except as set forth on Section 2.24 2.8 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.24 Schedule 2.22 of the Company Disclosure ScheduleLetter, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Poniard Pharmaceuticals, Inc.)
No Financial Advisor. Except as set forth on Section 2.24 2.23 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the CompanyGroup Companies.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Windtree Therapeutics Inc /De/)
No Financial Advisor. Except as set forth on Section 2.24 in Part 3.8 of the Company ONCE Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s 's fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger Share Exchange or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company ONCE or any Subsidiary of the CompanyISI.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.24 Part 3.22 of the Company Tranzyme Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Tranzyme or any Subsidiary of the CompanyTranzyme.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Tranzyme Inc)
No Financial Advisor. Except as set forth on Section 2.24 Part 2.23 of the Company Merger Partner Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Merger Partner or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Novacea Inc)
No Financial Advisor. Except as set forth on Section 2.24 Part 2.22 of the Company Buyer Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Buyer or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Organovo Holdings, Inc.)
No Financial Advisor. Except as set forth on Section 2.24 Part 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of Holdings, the Company or any Subsidiary of the Companytheir Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Proteostasis Therapeutics, Inc.)
No Financial Advisor. Except as set forth on Section 2.24 2.19 of the Company Quoin Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the CompanyQuoin.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Cellect Biotechnology Ltd.)
No Financial Advisor. Except as set forth on Section 2.24 2.23 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
No Financial Advisor. Except for as set forth on Section 2.24 2.22 of the Company VIA Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company VIA or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on in Section 2.24 2.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Restoration Robotics, Inc.)
No Financial Advisor. Except for the Equity Financing Transactions, the Specified Business and Assets Disposition, and as set forth on Section 2.24 3.18 of the Company Intec Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Intec or any Subsidiary of the CompanyIntec Subsidiary.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Intec Pharma Ltd.)
